Want to join the conversation?
$HAR 1Q16 operating income increased 14% to $131MM and EBITDA increased 23% to $188MM compared to the prior year. During the quarter, $HAR recorded $26MM of restructuring, non-recurring charges and acquisition-related items compared to $12MM in the prior year. The increase was primarily due to non-cash amortization of acquired intangible assets.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.